Literature DB >> 10074943

Structural and mechanistic basis of immunity toward endonuclease colicins.

C Kleanthous1, U C Kühlmann, A J Pommer, N Ferguson, S E Radford, G R Moore, R James, A M Hemmings.   

Abstract

The crystal structure of the cytotoxic endonuclease domain from the bacterial toxin colicin E9 in complex with its cognate immunity protein Im9 reveals that the inhibitor does not bind at the active site, the core of which comprises the HNH motif found in intron-encoded homing endonucleases, but rather at an adjacent position leaving the active site exposed yet unable to bind DNA because of steric and electrostatic clashes with incoming substrate. Although its mode of action is unorthodox, Im9 is a remarkably effective inhibitor since it folds within milliseconds and then associates with its target endonuclease at the rate of diffusion to form an inactive complex with sub-femtomolar binding affinity. This hyperefficient mechanism of inhibition could be well suited to other toxic enzyme systems, particularly where the substrate is a polymer extending beyond the boundaries of the active site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074943     DOI: 10.1038/6683

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  74 in total

1.  Treble clef finger--a functionally diverse zinc-binding structural motif.

Authors:  N V Grishin
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

2.  Biochemical characterization of I-CmoeI reveals that this H-N-H homing endonuclease shares functional similarities with H-N-H colicins.

Authors:  M Drouin; P Lucas; C Otis; C Lemieux; M Turmel
Journal:  Nucleic Acids Res       Date:  2000-11-15       Impact factor: 16.971

Review 3.  Homing endonucleases: structural and functional insight into the catalysts of intron/intein mobility.

Authors:  B S Chevalier; B L Stoddard
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

4.  Translocation of a functional protein by a voltage-dependent ion channel.

Authors:  Stephen L Slatin; Angèle Nardi; Karen S Jakes; Daniel Baty; Denis Duché
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

5.  HNH family subclassification leads to identification of commonality in the His-Me endonuclease superfamily.

Authors:  Preeti Mehta; Krishnamohan Katta; Sankaran Krishnaswamy
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

6.  Probing metal ion binding and conformational properties of the colicin E9 endonuclease by electrospray ionization time-of-flight mass spectrometry.

Authors:  Ewald T J van den Bremer; Wim Jiskoot; Richard James; Geoffrey R Moore; Colin Kleanthous; Albert J R Heck; Claudia S Maier
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

7.  Transcriptional profiling of colicin-induced cell death of Escherichia coli MG1655 identifies potential mechanisms by which bacteriocins promote bacterial diversity.

Authors:  Daniel Walker; Matthew Rolfe; Arthur Thompson; Geoffrey R Moore; Richard James; Jay C D Hinton; Colin Kleanthous
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

8.  DNA binding and cleavage by the periplasmic nuclease Vvn: a novel structure with a known active site.

Authors:  Chia-Lung Li; Lien-I Hor; Zee-Fen Chang; Li-Chu Tsai; Wei-Zen Yang; Hanna S Yuan
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

9.  Identification of the catalytic motif of the microbial ribosome inactivating cytotoxin colicin E3.

Authors:  Daniel Walker; Lorna Lancaster; Richard James; Colin Kleanthous
Journal:  Protein Sci       Date:  2004-05-07       Impact factor: 6.725

10.  Distinct conformational stability and functional activity of four highly homologous endonuclease colicins.

Authors:  Ewald T J van den Bremer; Anthony H Keeble; Wim Jiskoot; Robin E J Spelbrink; Claudia S Maier; Arie van Hoek; Antonie J W G Visser; Richard James; Geoffrey R Moore; Colin Kleanthous; Albert J R Heck
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.